Roger T Mulder Selected Research

Naltrexone (ReVia)

1/2019	Dispensing of medication for alcohol use disorder; an examination of large databases in a New Zealand context.
5/2015	OPRM1 genotype and naltrexone response in depressed alcohol-dependent patients.
3/2015	Depression outcome in alcohol dependent patients: an evaluation of the role of independent and substance-induced depression and other predictors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger T Mulder Research Topics

Disease

7	Personality Disorders (Personality Disorder) 06/2007 - 04/2002
6	Alcoholism (Alcohol Abuse) 01/2019 - 09/2014
4	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2014 - 01/2003
4	Depressive Disorder (Melancholia) 12/2003 - 02/2002
2	Mental Disorders (Mental Disorder) 05/2021 - 11/2014
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 06/2019
2	Postpartum Depression (Post-Natal Depression) 11/2014 - 03/2006
2	Major Depressive Disorder (Major Depressive Disorders) 01/2014 - 06/2007
2	Drug-Related Side Effects and Adverse Reactions 01/2004 - 02/2002
1	Schizophrenia (Dementia Praecox) 05/2021
1	Hemochromatosis (Bronze Diabetes) 06/2019
1	Chest Pain (Chest Pains) 01/2017
1	Sudden Infant Death (SID) 10/2015
1	Tobacco Use Disorder (Nicotine Dependence) 09/2014
1	Anxiety Disorders (Anxiety Disorder) 09/2014
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 09/2014
1	Mood Disorders (Mood Disorder) 03/2014
1	Psychotic Disorders (Schizoaffective Disorder) 12/2013
1	Panic Disorder (Panic Attack) 01/2010
1	Bulimia Nervosa 01/2008
1	Anorexia Nervosa 01/2008
1	Compulsive Personality Disorder (Obsessive Compulsive Personality) 06/2006
1	Self Mutilation 03/2006
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 03/2005
1	Chronic Disease (Chronic Diseases) 02/2002

Drug/Important Bio-Agent (IBA)

9	Antidepressive Agents (Antidepressants)IBA 01/2020 - 06/2002
5	Pharmaceutical PreparationsIBA 01/2020 - 01/2003
4	Nortriptyline (Aventyl)FDA LinkGeneric 01/2004 - 06/2002
4	Fluoxetine (Prozac)FDA LinkGeneric 01/2004 - 06/2002
3	Naltrexone (ReVia)FDA LinkGeneric 01/2019 - 03/2015
2	Citalopram FDA LinkGeneric 05/2015 - 03/2015
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2014 - 06/2006
2	neodymium pyrocatechin disulfonate (NPD)IBA 01/2010 - 01/2003
2	Dopamine D3 ReceptorsIBA 06/2006 - 07/2003
2	FenfluramineIBA 03/2003 - 04/2002
2	ProlactinIBA 03/2003 - 04/2002
1	Vitamin B 6IBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	ZincIBA 05/2021
1	PyrrolesIBA 05/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	IronIBA 06/2019
1	MicronutrientsIBA 06/2019
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2019
1	Disulfiram (Antabuse)FDA Link 01/2019
1	Illicit Drugs (Recreational Drugs)IBA 09/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014
1	5-HT1A Serotonin ReceptorIBA 01/2014
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2008
1	DNA (Deoxyribonucleic Acid)IBA 06/2006
1	GTP-Binding Proteins (G-Protein)IBA 03/2006
1	Opioid Analgesics (Opioids)IBA 03/2005
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2004
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2004
1	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 07/2003
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2003
1	A-factor (Streptomyces)IBA 02/2002

Therapy/Procedure

5	Therapeutics 01/2017 - 06/2007
1	Aftercare (After-Treatment) 12/2013
1	Cesarean Section (Caesarean Section) 03/2006
1	Drug Therapy (Chemotherapy) 02/2002